Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Publikationsliste der Klinischen Chemie

Publikationsliste der Klinischen Chemie


Neuner B, von Mackensen S, Kiesau B, Krampe H, McCarthy WJ, Reinke S, Kowalski D, Shneyder M, Clausnizer H, Rocke A, Junker R, Nowak-Göttl U. (2020) Cross-Sectional and Longitudinal Construct Validity of the Generic KINDL-A(dult)B(rief) Questionnaire in Adults with Thrombophilia or with Hereditary and Acquired Bleeding Disorders.  Acta Haematol. 1-9. doi: 10.1159/000507602. Online ahead of print. PMID: 32506056

Witten A, Rühle F, de Witt M, Barysenka A, Stach M, Junker R, Nowak-Göttl U, Stoll M. ADAMTS12, a new candidate gene for pediatric stroke. (2020) PLoS One. 15(8): e0237928. Published online 2020 Aug 20. doi: 10.1371/journal.pone.0237928

Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, Bordoni D, Franzenburg J, Geisen U, Josephs-Spaulding J, Köhler P, Künstner A, Rosati E, Aschenbrenner AC, Bacher P, Baran N, Boysen T, Brandt B, Bruse N, Dörr J, Dräger A, Elke G, Ellinghaus D, Fischer J, Forster M, Franke A, Franzenburg S, Frey N, Friedrichs A, Fuß J, Glück A, Hamm J, Hinrichsen F, Hoeppner MP, Imm S, Junker R, Kaiser S, Kan YH, Knoll R, Lange C, Laue G, Lier C, Lindner M, Marinos G, Markewitz R, Nattermann J, Noth R, Pickkers P, Rabe KF, Renz A, Röcken C, Rupp J, Schaffarzyk A, Scheffold A, Schulte-Schrepping J, Schunk D, Skowasch D, Ulas T, Wandinger KP, Wittig M, Zimmermann J, Busch H, Hoyer BF, Kaleta C, Heyckendorf J, Kox M, Rybniker J, Schreiber S, Schultze JL, Rosenstiel P. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. (2020) Immunity. 53(6): 1296-1314.

Appeltshauser L, Brunder AM, Heinius A, Körtvélyessy P, Wandinger KP, Junker R, Villmann C, Sommer C, Leypoldt F, Doppler K. Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropythy. (2020) Neurol Neuroimmunol Neuroinflamm. 7:e817.

Schlicht K, Rohmann N, Geisler C, Hollstein T, Knappe C, Hartmann K, Schwarz J, Tran F, Schunk D, Junker R, Behmer T, Rosenstiel P, Schulte D, Türk K, Franke A, Schreiber S, Laudes M. Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections. (2020) Int J Obes (Lond) 2020 Sep 21 : 1–4. doi: 10.1038/s41366-020-00689-y

Altintas A, Dargvainiene J, Schneider-Gold C, Asgari N, Ayzenberg I, Ciplea AI, Junker R, Leypoldt F, Wandinger KP, Hellwig K. Gender Issues of Antibody-Mediated Diseases in Neurology. (2020) Ther Adv Neurol Disord. 13: 1756286420949808. Published online 2020 Aug 25. doi: 10.1177/1756286420949808

Haeckel R, Wosniok W, Torge A, Junker R. Age- and sex-dependent reference intervals for uric acid estimated by the truncated minimum chi-square (TMC) approach, a new indirect method. (2020) J Lab Med 2020. 44(3): 157–163.

Haeckel R, Wosniok W, Torge A, Junker R. (2020) Reference limits of high-sensitive cardiac troponin T indirectly estimated by a new approach applying data mining. A special example for measurands with a relatively high percentage of values at or below the detection limit. J Lab Med 2020; aop.

Haeckel R, Wosniok W, Torge A, Junker R, Bertram A, Krebs A, Özcürümez M, Orth M, Streichert T. (2020) Age and sex dependent reference intervals for random plasma/serum glucose concentrations related to different sampling devices and determined by an indirect procedure with data mining. J Lab Med 2020; aop.

De Simoni D, Ricken G, Winklehner M, Koneczny I, Karenfort M, Hustedt U, Seidel U, Abdel-Mannan O, Munot P, Rinaldi S, Steen C, Freilinger M, Breu M, Seidl R, Reindl M, Wanschitz J, Lleixà C, Bernert G, Wandinger KP, Junker R, Querol L, Leypoldt F, Rostásy K, Höftberger R. Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy. (2020) Neurol Neuroimmunol Neuroinflamm. 7(4): e763. Published online 2020 Jun 1. doi: 10.1212/NXI.0000000000000763

Gövert F, Leypoldt F, Junker R, Wandinger KP, Deuschl G, Bhatia KP, Balint B. Antibody-related movement disorders – a comprehensive review of phenotype-autoantibody correlations and a guide to testing. (2020) Neurol Res Pract. 2020 Feb 20;2:6. doi: 10.1186/s42466-020-0053-x

Juhl D, Kuta P, Shneyder M, Wünsche F, Nowak-Göttl U. (2020) Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia. Acta Haematol. 10:1-4. doi: 10.1159/000508525. Online ahead of print. PMID: 32653888

Hartmann S, Biliouris K, Lesko LJ, Nowak-Göttl U, Trame MN. (2020) Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy.  Front Pharmacol. 11:1041. doi: 10.3389/fphar.2020.01041. eCollection 2020. PMID: 32765265

Goeggel Simonetti B, Rafay MF, Chung M, Lo WD, Beslow LA, Billinghurst LL, Fox CK, Pagnamenta A, Steinlin M, Mackay MT; IPSS Study Group (Nowak-Göttl U). (2020) Comparative study of posterior and anterior circulation stroke in childhood: Results from the International Pediatric Stroke Study. Neurology. 2020 Jan 28;94(4):e337-e344. doi: 10.1212/WNL.0000000000008837. Epub 2019 Dec 19. PMID: 31857436

Lindhoff-Last E, Herrmann E, Lindau S, Konstantinides S, Grottke O, Nowak-Goettl U, Lucks J, Zydek B, Heymann CV, Birschmann I, Sümnig A, Beyer-Westendorf J, Schellong S, Meybohm P, Greinacher A. (2020) Severe Hemorrhage Associated With Oral Anticoagulants. Dtsch Arztebl Int. 2020 May 1;117(18):312-319. doi: 10.3238/arztebl.2020.0312. PMID: 32605708

Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P; EINSTEIN-Jr Phase 3 Investigators (Nowak-Göttl U). (2020) Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5. PMID: 31699660 Clinical Trial.

Tumani H, Petereit HF, Gerritzen A, Gross CC, Huss A, Isenmann S, Jesse S, Khalil M, Lewczuk P, Lewerenz J, Leypoldt F, Melzer N, Meuth SG, Otto M, Ruprecht K, Sindern E, Spreer A, Stangel M, Strik H, Uhr M, Vogelgsang J, Wandinger KP, Weber T, Wick M, Wildemann B, Wiltfang J, Woitalla D, Zerr I, Zimmermann T. S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version). Neurol Res Pract. 2020 Mar 16;2:8. doi: 10.1186/s42466-020-0051-z. PMID: 33324914; PMCID: PMC7650145.

Bacher P, Rosati E, Esser D, Martini GR, Saggau C, Schiminsky E, Dargvainiene J, Schröder I, Wieters I, Khodamoradi Y, Eberhardt F, Vehreschild MJGT, Neb H, Sonntagbauer M, Conrad C, Tran F, Rosenstiel P, Markewitz R, Wandinger KP, Augustin M, Rybniker J, Kochanek M, Leypoldt F, Cornely OA, Koehler P, Franke A, Scheffold A. Low-Avidity CD4<sup>+</sup> T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19. Immunity. 2020 Dec 15;53(6):1258-1271.e5. doi: 10.1016/j.immuni.2020.11.016. Epub 2020 Nov 26. PMID: 33296686; PMCID: PMC7689350.

Körtvelyessy P, Kuhle J, Düzel E, Vielhaber S, Schmidt C, Heinius A, Leypoldt F, Schraven B, Reinhold D, Leppert D, Goihl A. Ratio and index of Neurofilament light chain indicate its origin in Guillain-Barré Syndrome. Ann Clin Transl Neurol. 2020 Nov;7(11):2213-2220. doi: 10.1002/acn3.51207. Epub 2020 Oct 8. PMID: 33030817; PMCID: PMC7664266.

Spatola M, Petit Pedrol M, Maudes E, Simabukuro M, Muñiz-Castrillo S, Pinto AL, Wandinger KP, Spiegler J, Schramm P, Dutra LA, Iorio R, Kornblum C, Bien CG, Höftberger R, Leypoldt F, Titulaer MJ, Sillevis Smitt P, Honnorat J, Rosenfeld MR, Graus F, Dalmau J. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology. 2020 Dec 1;95(22):e3012-e3025. doi: 10.1212/WNL.0000000000010854. Epub 2020 Sep 14. PMID: 32928978; PMCID: PMC7734921.

Endres D, Maier V, Leypoldt F, Wandinger KP, Lennox B, Pollak TA, Nickel K, Maier S, Feige B, Domschke K, Prüss H, Bechter K, Dersch R, Tebartz van Elst L. Autoantibody-associated psychiatric syndromes: a systematic literature review resulting in 145 cases. Psychol Med. 2020 Sep 7:1-12. doi: 10.1017/S0033291720002895. Epub ahead of print. PMID: 32892761.

Endres D, Leypoldt F, Bechter K, Hasan A, Steiner J, Domschke K, Wandinger KP, Falkai P, Arolt V, Stich O, Rauer S, Prüss H, van Elst LT. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations. Eur Arch Psychiatry Clin Neurosci. 2020 Oct;270(7):803-818. doi: 10.1007/s00406-020-01113-2. Epub 2020 Mar 12. PMID: 32166503; PMCID: PMC7474714.

Jarius S, Lechner C, Wendel EM, Baumann M, Breu M, Schimmel M, Karenfort M, Marina AD, Merkenschlager A, Thiels C, Blaschek A, Salandin M, Leiz S, Leypoldt F, Pschibul A, Hackenberg A, Hahn A, Syrbe S, Strautmanis J, Häusler M, Krieg P, Eisenkölbl A, Stoffels J, Eckenweiler M, Ayzenberg I, Haas J, Höftberger R, Kleiter I, Korporal-Kuhnke M, Ringelstein M, Ruprecht K, Siebert N, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, Rostásy K; in cooperation with the BIOMARKER study group and the Neuromyelitis optica Study Group (NEMOS). Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients. J Neuroinflammation. 2020 Sep 3;17(1):262. doi: 10.1186/s12974-020-01825-1. PMID: 32883358; PMCID: PMC7470445.

Wickel J, Chung HY, Platzer S, Lehmann T, Prüss H, Leypoldt F, Günther A, Scherag A, Geis C; GENERATE Study Group. Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis. Trials. 2020 Jul 8;21(1):625. doi: 10.1186/s13063-020-04516-7. PMID: 32641101; PMCID: PMC7346383.

Bader JM, Geyer PE, Müller JB, Strauss MT, Koch M, Leypoldt F, Koertvelyessy P, Bittner D, Schipke CG, Incesoy EI, Peters O, Deigendesch N, Simons M, Jensen MK, Zetterberg H, Mann M. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease. Mol Syst Biol. 2020 Jun;16(6):e9356. doi: 10.15252/msb.20199356. PMID: 32485097; PMCID: PMC7266499.

Stürner KH, Werz O, Koeberle A, Otto M, Pless O, Leypoldt F, Paul F, Heesen C. Lipid Mediator Profiles Predict Response to Therapy with an Oral Frankincense Extract in Relapsing-Remitting Multiple Sclerosis. Sci Rep. 2020 May 29;10(1):8776. doi:  10.1038/s41598-020-65215-6. PMID: 32472007; PMCID: PMC7260364.

Syrbe S, Stettner GM, Bally J, Borggraefe I, Bien CI, Ferfoglia RI, Huppke P, Kern J, Polster T, Probst-Müller E, Schmid S, Steinfeld R, Strozzi S, Weichselbaum A, Weitz M, Ziegler A, Wandinger KP, Leypoldt F, Bien CG. CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension. Neurology. 2020 Jun 2;94(22):e2290-e2301. doi: 10.1212/WNL.0000000000009523. Epub 2020 May 18. PMID: 32424051.

Wegener-Panzer A, Cleaveland R, Wendel EM, Baumann M, Bertolini A, Häusler M, Knierim E, Reiter-Fink E, Breu M, Sönmez Ö, Della Marina A, Peters R, Lechner C, Piepkorn M, Roll C, Höftberger R, Leypoldt F, Reindl M, Rostásy K. Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies. Neurol Neuroimmunol Neuroinflamm. 2020 May 1;7(4):e731. doi: 10.1212/NXI.0000000000000731. PMID: 32358225; PMCID: PMC7217659.

Pawlitzki M, Campe C, Rolfes L, Heinze HJ, Leypoldt F, Wandinger KP, Reindl M, Wildemann B, Jarius S, Körtvelyessy P. Transient MOG antibody seroconversion associated with immunomodulating therapy. Mult Scler Relat Disord. 2020 Jan;37:101420. doi: 10.1016/j.msard.2019.101420. Epub 2019 Sep 28. PMID: 32172994.

Geritz J, Maetzold S, Steffen M, Pilotto A, Corrà MF, Moscovich M, Rizzetti MC, Borroni B, Padovani A, Alpes A, Bang C, Barcellos I, Baron R, Bartsch T, Becktepe JS, Berg D, Bergeest LM, Bergmann P, Bouça-Machado R, Drey M, Elshehabi M, Farahmandi S, Ferreira JJ, Franke A, Friederich A, Geisler C, Hüllemann P, Gierthmühlen J, Granert O, Heinzel S, Heller MK, Hobert MA, Hofmann M, Jemlich B, Kerkmann L, Knüpfer S, Krause K, Kress M, Krupp S, Kudelka J, Kuhlenbäumer G, Kurth R, Leypoldt F, Maetzler C, Maia LF, Moewius A, Neumann P, Niemann K, Ortlieb CT, Paschen S, Pham MH, Puehler T, Radloff F, Riedel C, Rogalski M, Sablowsky S, Schanz EM, Schebesta L, Schicketmüller A, Studt S, Thieves M, Tönges L, Ullrich S, Urban PP, Vila-Chã N, Wiegard A, Warmerdam E, Warnecke T, Weiss M, Welzel J, Hansen C, Maetzler W. Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment - the ComOn-study. BMC Geriatr. 2020 Feb 6;20(1):45. doi: 10.1186/s12877-020-1445-z. PMID: 32028945; PMCID: PMC7006407.

Joubert B, García-Serra A, Planagumà J, Martínez-Hernandez E, Kraft A, Palm F, Iizuka T, Honnorat J, Leypoldt F, Graus F, Dalmau J. Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series. Neurol Neuroimmunol Neuroinflamm. 2020 Jan 16;7(3):e668. doi: 10.1212/NXI.0000000000000668. PMID: 31948997; PMCID: PMC7051205.

Markewitz, R., Pauli, D., Wandinger, K.P. (2020) The modern epidemic of syphilis. N. Engl. J. Med. 382: 2379-2380

Markewitz, R.D.H, Wandinger, K.P. (2020) Terminology and definition of “antinuclear antibodies”: history and current debate. Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2020-217166

Markewitz RDH, Graf T. (2020) Capnocytophaga canimorsus infection. N Engl J Med, 383(12): 1167

Neuromyelitis Optica Study Group (NEMOS). (2020) Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders. Neurology doi: 10.1212/WNL.0000000000008684. Epub 2019 Dec 3

Hendricks A, Brandt B, Geisen R, Dall K, Röder C, Schafmayer C, Becker T, Hinz S, Sebens S Isolation and Enumeration of CTC in Colorectal Cancer Patients: Introduction of a Novel Cell Imaging Approach and Comparison to Cellular and Molecular Detection Techniques. (2020). Cancers (Basel). 12(9):2643

Nastały P, Stoupiec S, Popęda M, Smentoch J, Schlomm T, Morrissey C, Żaczek AJ, Beyer B, Tennstedt P, Graefen M, Eltze E, Maiuri P, Semjonow A, Pantel K, Brandt B, Bednarz-Knoll N EGFR as a stable marker of prostate cancer dissemination to bones. (2020). Br J Cancer (London). 123(12):1767-1774

Sonntag B, Eisemann N, Elsner S, Ludwig AK, Katalinic A, Kixmüller D, Ludwig M. (2020) Pubertal development and reproductive hormone levels of singleton ICSI offspring in adolescence: results of a prospective controlled study. Hum Reprod. 35(4):968-976

Elsner S, Katalinic A, Ludwig AK, Sonntag B, Martensen MJ, Kixmüller D, Eisemann N, Ludwig M. (2020) A comparison of metabolic health parameters in ICSI-conceived and naturally conceived adolescents. Reprod Biomed Online. 41(4):686-697

Kruse T, Gnosa SP, Nasa I, Garvanska DH, Hein JB, Nguyen H, Samsøe-Petersen J, Lopez-Mendez B, Hertz EPT, Schwarz J, Pena HS, Nikodemus D, Kveiborg M, Kettenbach AN, Nilsson J., Mechanisms of site-specific dephosphorylation and kinase opposition imposed by PP2A regulatory subunits. EMBO J . 2020 Jul 1;39(13):e103695. doi: 10.15252/embj.2019103695. Epub 2020 May 13.




Poschenrieder A, Thaler M, Junker R, Luppa PB: Recent advances in immunodiagnostics based on biosensor technologies – from central laboratory to the point of care. Anal Bioanal Chem 2019 Nov;411(29):7607-7621. doi: 10.1007/s00216-019-01915-x. Epub 2019 May 31

Weimar C, Holzhauer S, Knoflach M, Koennecke HC, Masuhr F, Mono ML, Niederstadt T, Nowak-Göttl U, Schellong SM, Kurth T: [Cerebral venous and sinus thrombosis: S2k guidelines]. Nervenarzt. 2019 Apr;90(4):379-387. doi:10.1007/s00115-018-0654-6. Review. German. PubMed PMID: 30758512.

Nowak-Göttl U, Miesbach W, Koscielny J, Dempfle CE, Maegele M, ProndzinskiMVD, Westrup D, Spannagl M: Replacement Therapy in Patients with Von WillebrandDisease-Indications and Monitoring. Hamostaseologie. 2019 Nov;39(4):326-338. doi:10.1055/s-0039-1692688. Epub 2019 Jul 30. PubMed PMID: 31364093.

Monagle P, Lensing AWA, Thelen K, Martinelli I, Male C, Santamaría A,Samochatova E, Kumar R, Holzhauer S, Saracco P, Simioni P, Robertson J, Grangl G,Halton J, Connor P, Young G, Molinari AC, Nowak-Göttl U, Kenet G, Kapsa S,Willmann S, Pap AF, Becka M, Twomey T, Beyer-Westendorf J, Prins MH, Kubitza D: EINSTEIN-Jr Phase 2 Investigators. Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre,single-arm, phase 2 studies. Lancet Haematol. 2019 Oct;6(10):e500-e509. oi:10.1016/S2352-3026(19)30161-9. Epub 2019 Aug 13. PubMed PMID: 31420317.

Kenet G, Cohen O, Bajorat T, Nowak-Göttl U: Insights into neonatal thrombosis.Thromb Res. 2019 Sep;181 Suppl 1:S33-S36. doi: 10.1016/S0049-3848(19)30364-0.Review. PubMed PMID: 31477225.

deVeber G, Kirkham F, Shannon K, Brandão L, Sträter R, Kenet G, Clausnizer H, Moharir M, Kausch M, Askalan R, MacGregor D, Stoll M, Torge A, Dlamini N, GanesanV, Prengler M, Singh J, Nowak-Göttl U. Recurrent stroke: the role ofthrombophilia in a large international pediatric stroke population.Haematologica. 2019 Aug;104(8):1676-1681. doi: 10.3324/haematol.2018.211433. Epub 2019 Jan 24. Erratum in: Haematologica. 2019 Oct;104(10):2116. PubMed PMID:0679327; PubMed Central PMCID: PMC6669164.

Schuster S, Abrante L, Matschke J, Lütgehetmann M, Holst B, Gelderblom M, Braass H, Leypoldt F, Magnus T: (2019) Fatal PCR-negative herpes simplex virus-1 encephalitis with GABA(A) receptor antibodies Neurol Neuroimmunol Neuroinflamm. 2019 Sep 25;6(6):e624. doi: 10.1212/NXI.0000000000000624. Print 2019 Nov.

Lamby N, Leypoldt F, Schulz JB, Tauber SC: (2019) Atypical presentation of anti-Ma2-associated encephalitis with choreiform movement Neurol Neuroimmunol Neuroinflamm. 2019 Apr 1;6(3):e557. doi: 10.1212/NXI.0000000000000557. eCollection 2019 May.

Endres D, Bechter K, Prüss H, Hasan A, Steiner J, Leypoldt F, Tebartz van Elst L: (2019) [Autoantibody-associated schizophreniform psychoses: clinical symptomatology] Nervenarzt. 2019 May;90(5):547-563. doi: 10.1007/s00115-019-0700-z.

Tebartz van Elst L, Bechter K, Prüss H, Hasan A, Steiner JH, Leypoldt F, Endres D: (2019) [Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment] Nervenarzt. 2019 Jul;90(7):745-761. doi: 10.1007/s00115-019-0735-1.

Rempe T, Becktepe JS, Metz I, Brück W, Stürner KH, Deuschl G, Berg D, Baron R, Zeuner R, Leypoldt F: (2019) A case of CLIPPERS syndrome responsive to tocilizumab Neurol Neuroimmunol Neuroinflamm. 2019 Feb 1;6(3):e545. doi: 10.1212/NXI.0000000000000545. eCollection 2019 May.

Gold SM, Willing A, Leypoldt F, Paul F, Friese MA: (2019) Sex differences in autoimmune disorders of the central nervous system Semin Immunopathol. 2019 Mar;41(2):177-188. doi: 10.1007/s00281-018-0723-8. Epub 2018 Oct 25.

Baumgartner A, Rauer S, Hottenrott T, Leypoldt F, Ufer F, Hegen H, Prüss H, Lewerenz J, Deisenhammer F, Stich O. (2019) Admission diagnoses of patients later diagnosed with autoimmune encephalitis J Neurol. 2019 Jan;266(1):124-132. doi: 10.1007/s00415-018-9105-3. Epub 2018 Nov 12.

Lieb W, Jacobs G, Wolf A, Richter G, Gaede KI, Schwarz J, Arnold N, Böhm R, Buyx A, Cascorbi I, Franke A, Glinicke C, Held-Feindt J, Junker R, Kalthoff H, Kramer HH, Leypoldt F, Maass N, Maetzler W, May S, Mehdorn HM, Röcken C, Schafmayer C, Schrappe M, Schreiber S, Sebens S, Stephani U, Synowitz M, Weimer J, Zabel P, Nöthlings U, Röder C, Krawczak M. (2019) Linking pre-existing biorepositories for medical research: the PopGen 2.0 Network J Community Genet. 2019 Oct;10(4):523-530. doi: 10.1007/s12687-019-00417-8. Epub 2019 Mar 29.

Hopfner F, Müller SH, Steppat D, Miller J, Schmidt N, Wandinger KP, Leypoldt F, Berg D, Franke A, Lieb W, Tittmann L, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Hilker-Roggendorf R, Kalbe E, Kassubek J, Klockgether T, Liepelt-Scarfone I, Mollenhauer B, Neuser P, Reetz K, Riedel O, Schulte C, Schulz JB, Spottke A, Storch A, Trenkwalder C, Wittchen HU, Witt K, Wüllner U, Deuschl G, Kuhlenbäumer G. (2019) No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors Transl Neurodegener. 2019 Apr 3;8:11. doi: 10.1186/s40035-019-0153-0. eCollection 2019.

Stengel H, Vural A, Brunder AM, Heinius A, Appeltshauser L, Fiebig B, Giese F, Dresel C, Papagianni A, Birklein F, Weis J, Huchtemann T, Schmidt C, Körtvelyessy P, Villmann C, Meinl E, Sommer C, Leypoldt F*, Doppler K*. (2019) Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy Neurol Neuroimmunol Neuroinflamm. 2019 Aug 16;6(5):e603. doi: 10.1212/NXI.0000000000000603. Print 2019 Sep. *equally contributing

Bartsch T, Rempe T, Leypoldt F, Riedel C, Jansen O, Berg D, Deuschl G. (2019) The spectrum of progressive multifocal leukoencephalopathy: a practical approach Eur J Neurol. 2019 Apr;26(4):566-e41. doi: 10.1111/ene.13906. Epub 2019 Feb 8.

Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F. (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models Lancet Neurol. 2019 Nov;18(11):1045-1057. doi: 10.1016/S1474-4422(19)30244-3. Epub 2019 Jul 17.

Laudes, M, Frohnert, J, Ivanova, K, Wandinger, KP (2019) PTH immunoassay interference due to human anti-mouse antibodies in an obese human subject with normal parathyroid function. J. Clin. Endocrinol. Metab. 104:5840-5842

Royl, G, Fokou, T F, Chunder, R, Isa, R, Münte, T F, Wandinger, K P, Schwaninger, M, Herrmann, O, Valdueza, J M, Brocke, J, Willkomm, M, Willemsen, D, Auffarth, G U, Mindorf, S, Brix, B, Chamorro, Planas, A, Urra, X: (2019) Antibodies against neural antigens in patients with acute stroke: joint results of three independent cohort studies. J. Neurol. 266:2772-2779

Koch, H, Niturad, C.E, Theiss, S, Bien, C.G, Elger, C, Wandinger, KP, Vincent, A., Malter, M., Körtvélyessy, P., Lerche, H., Dihné, M: (2019) In vitro neuronal network activity as a new functional diagnostic system to detect effects of cerebrospinal fluid from autoimmune encephalitis patients. Sci. Rep. Apr 3;9:5591 doi: 10.1038/s41598-019-41849-z

Wagner-Altendorf, TA, Wandinger, KP, Frydrychowicz, A, Merseburger, A, Münte, TF: (2019) Amphiphysin-associated limbic encephalitis in a 72-year old individual with aortal angiosarcoma. BMJ Case Reports Mar 14;12 doi: 10.1136/bcr-2018-226798

Borsche, M, Hahn, S, Hanssen, H, Münchau, A, Wandinger, KP, Brüggemann, N: (2019) Sez6l2-antibody-associated progressive cerebellar ataxia - a differential diagnosis of atypical parkinsonism. J. Neurol. 266:522-524; doi: 10.1007/s00415-018-9115-1

Smentoch J, Szade J, Żaczek AJ, Eltze E, Semjonow A, Brandt B, Bednarz-Knoll N: Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy, Cancers (Basel). 2019 Sep 12;11(9):1356. doi: 10.3390

Bednarz-Knoll N, Eltze E, Semjonow A, Brandt B: BRCAness in prostate cancer, Oncotarget. 2019 Mar 29;10(25):2421-2422. doi: 10.18632/oncotarget.26818. eCollection 2019 Mar 29.

Nastały P, Filipska M, Morrissey C, Eltze E, Semjonow A, Brandt B, Pantel K, Bednarz-Knoll N:  ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer,Transl Res. 2019 Jan;203:49-56. doi: 10.1016/j.trsl.2018.08.007. Epub 2018 Sep 12.

Omari A, Nastały P, Stoupiec S, Bałabas A, Dąbrowska M, Bielińska B, Huss S, Pantel K, Semjonow A, Eltze E, Brandt B, Bednarz-Knoll N: Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer, Int J Cancer. 2019 Feb 1;144(3):607-614. doi: 10.1002/ijc.31905. Epub 2018 Oct 22.


Junker R: Konsolidierung der Labordiagnostik an einem Uniklinikum. Management & Krankenhaus 2018; 3:2.

Poschenrieder A, Junker R, Luppa PB: Immunodiagnostics in Point-of-Care Testing. Biotechnology Advances. Invited Review, submitted,

Nowak-Göttl U, van Ommen H, Kenet G: Thrombophilia testing in children: What and when should be tested? Thromb Res 2018; 164: 75-8.

Kenet G, Barg AA, Nowak-Göttl U: Hemostasis in the Very Young. Semin Thromb Hemost 2018; doi: 10.1055/s-0038-1660852. Epub 2018 Jun 18.

Witten A, Bolbrinker J, Barysenka A, Huber M, Rühle F, Nowak-Göttl U, Garbe E, Kreutz R, Stoll M: Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study. J Mol Med 2018; doi: 10.1007/s00109-018-1661-6. Epub 2018 Jun 22.

Juhl D, Nowak-Göttl U, Blümel J, Görg S, Hennig H. Lack of evidence for the transmission of hepatitis E virus by coagulation factor concentrates based on seroprevalence data. Transfus Med. 2018 Dec;28(6):427-432. doi:10.1111/tme.12498. Epub 2017 Dec 27. PubMed PMID: 29280212.

Lensing AWA, Male C, Young G, Kubitza D, Kenet G, Patricia Massicotte M, Chan A, Molinari AC, Nowak-Göttl U, Pap ÁF, Adalbo I, Smith WT, Mason A, Thelen K, Berkowitz SD, Crowther M, Schmidt S, Price V, Prins MH, Monagle P. Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study. Thromb J. 2018 Dec 21;16:34. doi: 10.1186/s12959-018-0188-y. eCollection 2018. PubMed PMID: 30598642; PubMed Central PMCID: PMC6302520.

Neuner B, Krampe H, McCarthy WJ, Reinke S, Kowalski D, Clausnizer H, Shneyder M, Rocke A, Nowak-Göttl U: Psychometric Properties of a Modified KINDL-R Questionnaire for Adolescents and Adults, and Construction of a Brief Version, the KINDL-A(dult)B(rief) Questionnaire, KINDL-AB. Acta Haematol 2018; 140: 1-9.

Borsche M, Hahn S, Hanßen H, Münchau A, Wandinger KP, Brüggemann N: Sez6l2-antibody-associated progressive cerebellar ataxia - a differential diagnosis of atypical parkinsonism. J. Neurol. doi: 10.1007/s00415-018-9115-1

Hasselbacher K, Steffen A, Wandinger KP: Brüggemann N: IgLON5 antibodies are infrequent in patients with isolated sleep apnea. Eur J Neurol 2018; 25: e46-e47. doi: 10.1111/ene.13566.

Moser A, Hanssen H, Wandinger KP: Excessively increased CSF glutamate levels in GABAB-receptor antibody associated encephalitis: A case report. J Neurol Sci 2018; 388: 10-11. 

Prasuhn J, Royl G, Wandinger KP, Brüggemann N, Neumann A, Münte TF: Transient generalized chorea-athethosis in influenza A encephalopathy: Tremor Other Hyperkinet. Mov. doi: 10.7916/D8F495TP

Heine J, Prüss H, Kopp UA, Wegner F, Then Bergh F, Münte T, Wandinger KP, Paul F, Bartsch T, Finke C: Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis. J Neurol Neurosurg Psychiatry 2018; pii: jnnp-2017-317780. doi: 10.1136/jnnp-2017-317780. Epub 2018 Jun 9.

Schulte DM, Paulsen K, Türk K, Brandt B, Freitag-Wolf S, Hagen I, Zeuner R, Schröder JO, Lieb W, Franke A, Nikolaus S, Mrowietz U, Gerdes S, Schreiber S, Laudes M: Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases. Nutr Metab Cardiovasc Dis. 2018 Nov;28(11):1100-1105. doi: 10.1016/j.numecd. 2018.06.022. Epub 2018 Jul 4.

Omari A, Nastały P, Stoupiec S, Bałabas A, Dąbrowska M, Bielińska  B, Huss S, Pantel K, Semjonow A, Eltze E, Brandt B, Bednarz-Knoll N: Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer. Int J Cancer. 2019 Feb 1;144(3):607-614. doi: 10.1002/ijc.31905. Epub 2018 Oct 22.

Nastały P, Filipska M, Morrissey C, Eltze E, Semjonow A, Brandt B, Pantel K, Bednarz-Knoll N: ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer. Transl Res. 2019 Jan;203:49-56. doi: 10.1016/j.trsl.2018.08.007. Epub 2018 Sep 12.

Wandinger KP, Leypoldt F, Junker R: Autoantibody-associated encephalitis. Deut Ärzteblatt 2018; 115: 666-673.

Leypoldt F, Junker R, Wandinger KP: Hightech im Labor – Neuronale Autoantikörper ermöglichen den Nachweis bislang unbekannter Krankheitsbilder. Management & Krankenhaus Sonderheft kompakt 2018; 9:26.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F, German Network for Research on Autoimmune Encephalitis (GENERATE): Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Ann Neurol 2018; 83: 863-69.

Dulovic M, Schäffer E, Leypoldt F, Balck A, Schaake S, Hinrichs F, Kirchner H, Brüggemann N, Berg D, Lohmann K: A Klinefelter patient with an additional mitochondrial mutation: Implications for genotype-driven treatment and mitochondrial mutational load in different tissues and family members. Parkinsonism Relat Disord 2018; pii: S1353-8020(18)30146-9. doi: 10.1016/j.parkreldis.2018.04.001. Epub 2018 Apr 3.

Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B: MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature. J Neuroinflammation 2018; 15: 88. "

Pawlitzki M, Schreiber S, Bittner D, Kreipe J, Leypoldt F, Rupprecht K, Carare RO, Meuth SG, Vielhaber S, Körtvélyessy P: CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration. Front Neurol. 2018 Dec 14;9:1037. doi: 10.3389/fneur.2018.01037. eCollection 2018.

Schubert J, Brämer D, Huttner HB, Gerner ST, Fuhrer H, Melzer N, Dik A, Prüss H, Ly LT, Fuchs K, Leypoldt F, Nissen G, Schirotzek I, Dohmen C, Bösel J, Lewerenz J, Thaler F, Kraft A, Juranek A, Ringelstein M, Sühs KW, Urbanek C, Scherag A, Geis C, Witte OW, Günther A; GENERATE and IGNITE network: Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment. Neurol Neuroimmunol Neuroinflamm. 2018 Oct 30;6(1):e514. doi: 10.1212/NXI.0000000000000514. eCollection 2019 Jan.

Yilmaz R, Strafella AP, Bernard A, Schulte C, van den Heuvel L, Schneiderhan-Marra N, Knorpp T, Joos TO, Leypoldt F, Geritz J, Hansen C, Heinzel S, Apel A, Gasser T, Lang AE, Berg D, Maetzler W, Marras C: Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease. Front Neurol. 2018 Dec 21;9:1123. doi: 10.3389/fneur.2018.01123. eCollection 2018.

Elisak M, Krysl D, Hanzalova J, Volna K, Bien CG, Leypoldt F, Marusic P. The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients. Seizure. 2018 Dec;63:1-6. doi: 10.1016/j.seizure.2018.09.009. Epub 2018 Sep 17.

Gold SM, Willing A, Leypoldt F, Paul F, Friese MA: Sex differences in autoimmune disorders of the central nervous system. Semin Immunopathol. 2018 Oct 25. doi: 10.1007/s00281-018-0723-8. [Epub ahead of print]

Körtvelyessy P, Prüss H, Thurner L, Maetzler W, Vittore-Welliong D, Schultze-Amberger J, Heinze HJ, Reinhold D, Leypoldt F, Schreiber S, Bittner D: Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis. Front Neurol. 2018 Sep 19;9:668. doi: 10.3389/fneur.2018.00668. eCollection 2018 PMID: 30283395

Vashist S, Luong J, Luppa P, Junker R: Future POCT systems. In: Luppa P, Junker R (Hrsg.): Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 413-419.

Junker R, Wahl HG: POCT in the physician practice setting. In: Luppa P, Junker R (Hrsg.):Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 313-317.

Gässler N, Luppa P, Bietenbeck A, Petersmann A, Pröbstl A, Romann D, Junker R: Implementation of POCT. In: Luppa P, Junker R (Hrsg.): Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 303-312.

Gässler N, Junker R, Langer C, Schäfer B: Economic aspects of POCT. In: Luppa P, Junker R (Hrsg.): Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 295-300.

Kixmüller D, Gässler N, Junker R: Hematological diagnostics. In: Luppa P, Junker R (Hrsg.): Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 155-157.

Luppa P, Junker R, Schimke I, Stürenburg E: Immunological methods. In: Luppa P, Junker R (Hrsg.): Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 69-78.

Junker R, Gässler N: Clinical chemistry parameters. In: Luppa P, Junker R (Hrsg.): Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 63-68.

Kixmüller D, Junker R: Analysis of cellular blood components. In: Luppa P, Junker R (Hrsg.): Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 57-61.

Junker R, Petersmann A, Luppa P: The relevance of POCT in healthcare. In: Luppa P, Junker R (Hrsg.): Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 9-16.

Luppa P, Junker R, Langer C: Definitions and areas of application. In: Luppa P, Junker R (Hrsg.): Point-of-Care-Testing. Berlin, Heidelberg, New York: Springer 2018; 3-7.


Körtvélyessy P, Breu M, Pawlitzki M, Metz I, Heinze HJ, Matzke M, Mawrin C, Rommer P, Kovacs GG, Mitter C, Reindl M, Brück W, Wandinger KP, Lassmann H, Höftberger R, Leypoldt F: ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports. Neurol Neuroimmunol Neuroinflamm 2017; 4: e335.  doi: 10.1212/NXI.0000000000000335. eCollection 2017 May.

Miske R, Gross CC, Scharf M, Golombeck KS, Hartwig M, Bhatia U, Schulte-Mecklenbeck A, Bönte K, Strippel C, Schöls L, Synofzik M, Lohmann H, Dettman IM, Deppe M, Mindorf S, Warnecke T, Denno Y, Teegen B, Probst C, Brakopp S, Wandinger KP, Wiendl H, Stöcker W, Meuth SG, Komorowski L, Melzer N: Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm 2017; 4: e307.

Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T: Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis with Leicine. Rich, Glioma-Inactivated 1 Antibodies. JAMA Neurol 2017; 74: 50-9.

Juhl D, Nowak-Göttl U, Blümel J, Görg S, Hennig H: Lack of evidence for the transmission of hepatitis E virus by coagulation factor concentrates based on seroprevalence data. Transfus Med 2017; doi: 10.1111/tme.12498. Epub 2017 Dec 27.

Nowak-Göttl U, Dietrich K, Kruempel A, Geisen C, Mitchell LG: The VKORC1 and CYP2C9 genotypes significantly effect Vitamin K antagonist dosing only in patients over the age of 20years. Blood Cells Mol Dis 2017; 67: 54-8.

Kenet G, Nowak-Göttl U: Editorial for special pediatric hemostasis issue BCMD. Blood Cells Mol Dis. 2017; 67: 1.

Boeckelmann D, Hengartner H, Greinacher A, Nowak-Göttl U, Sachs UJ, Peter K, Sandrock-Lang K, Zieger B: Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype. Blood Cells Mol Dis 2017; 67: 69-74.

Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, Clausnizer H, Liebsch J, Junker R, Steppat D: Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67: 2-13.

Strauss T, Elisha N, Ravid B, Rosenberg N, Lubetsky A, Levy-Mendelovich S, Morag I, Nowak-Göttl U, Kenet G: Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Blood Cells Mol Dis 2017; 67: 14-7.

Kenet G, Limperger V, Shneyder M, Nowak-Göttl U: Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20 years? Blood Cells Mol Dis 2017; 67: 18-22.

Nowak-Göttl U, Clausnizer H, Kowalski D, Limperger V, Krümpel A, Shneyder M, Reinke S, Rocke A, Juhl D, Steppat D, Krause M: Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disorders. Blood Cells Mol Dis 2017; 67: 96-101.

Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, Clausnizer H, Liebsch J, Junker R, Steppat D: Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67: 2-13.

van Ommen CH, Nowak-Göttl U: Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test. Front Pediatr 2017; 5: 50.

Sultan S, Dowling M, Kirton A, DeVeber G, Linds A, Elkind MSV; IPSS Investigators: Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence and Risk Factors. Pediatr Neurol 2018; 78: 46-54.

Haussleiter IS, Wandinger KP, Juckel G: A case of GABAR antibodies in schizophrenia. BMC Psychiatry 2017; 17: 9.

Malviya M, Barman S, Golombeck KS, Planagumà J, Mannara F, Strutz-Seebohm N, Wrzos C, Demir F, Baksmeier C, Steckel J, Falk KK, Gross CC, Kovac S, Bönte K, Johnen A, Wandinger KP, Martín-García E, Becker AJ, Elger CE, Klöcker N, Wiendl H, Meuth SG, Hartung HP, Seebohm G, Leypoldt F, Maldonado R, Stadelmann C, Dalmau J, Melzer N, Goebels N: NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody. Ann Clin Trans Neurol 2017; 4: 768-83.

Obermayr E, Bednarz-Knoll N, Orsetti B, Weier HU, Lambrechts S, Castillo-Tong DC, Reinthaller A, Braicu EI, Mahner S, Sehouli J, Vergote I, Theillet C, Zeillinger R, Brandt B. Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium. Oncotarget.  2017; 8:106415-106428. doi: 10.18632/oncotarget.22468. eCollection 2017. Dec 5.

Hahn S, Trendelenburg G, Scharf M, Denno Y, Brakopp S, Teegen B, Probst C, Wandinger KP, Buttmann M, Haarmann A, Szabados F, vom Dahl M, Kümpfel T, Eichhorn P, Gold HJ, Paul, F, Jarius S, Melzer N, Stöcker W, Komorowsk L: Identification of the flotilin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis. J Neuroinflamm 2017; 14: 123.

Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan S, Komorowski L, Luo J, Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidaq A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F. Mechanisms of autoantibody-induced pathology. Front Immunol 2017; 8: 603.

Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, Brantner-Inthaler S, Diepold K, Eisenkölbl A, Gotwald T, Kuchukhidze G, Gruber-Sedlmayr U, Häusler M, Höftberger R, Karenfort M, Klein A, Koch J, Kraus V, Lechner C, Leiz S, Leypoldt F, Mader S, Marquard K, Poggenburg I, Pohl D, Pritsch M, Raucherzauner M, Schimmel M, Thiels C, Tibussek D, Vieker S, Zeches C, Berger T, Reindl M, Rostásy K, BIOMARKER Study Group: Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology 2017; 89: 900-8.

Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Marti  MJ, Montojo T, Perez-Perez J, Puertas , Seitz C, Simabukur M, Tellez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaria J, Dalmau J: Clinical manifestations of the anti-IgLON5 disease. Neurology 2017; 88: 1746-3.

Koch M, Furtado JD, Falk K, Leypoldt F, Mukamal KJ, Jensen MK: Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma. Alzheimers Dement (Amst) 2017; 6: 182-7. 

Finke C, Prüss H, Heine J, Reuter S, Kopp U, Wegner F, Berg F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T:  Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma inactivated 1 antibodies. JAMA Neurol 2017; 74: 50-9.

Rühle F, Witten A, Barysenka A, Huge A, Arning A, Heller C, Krümpel A, Mesters R, Franke A, Lieb W, Riemenschneider M, Hiersche M, Limperger V, Nowak-Göttl U, Stoll M: Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism. Blood 2017; 129: 783-90.

Nicolaus S, Schlulte B, Al-Massad N, Thieme F, Schulte DM, Bethge J, Rehmann A, Tran F, Aden K, Häsler R, Moll N, Schütze G, Schwarz MJ, Waetzig GH, Rosenstiel P, Krawczak M, Syzmchak S, Schreiber S: Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases. Gastroenterology 2017; 153: 1504-16.

Vashist S, Luong J, Luppa P, Junker R: Zukünftige POCT-Systeme. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 415-421.

Junker R, Wahl HG: POCT in der Arztpraxis. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 313-317.

Gässler N, Luppa P, Bietenbeck A, Petersmann A, Pröbstl A, Romann D, Junker R: Implementierung von POCT. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 303-312.

Gässler N, Junker R, Langer C, Schäfer B: Ökonomische Aspekte von POCT. In: Luppa P, Junker R, (Hrsg.). POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 295-300.

Kixmüller D, Gässler N, Junker R: Hämatologische Diagnostik. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 159-161.

Luppa P, Junker R, Schimke I, Stürenburg E: Immunologische Verfahren. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 73-83.

Junker R, Gässler N: Klinisch-chemische Parameter. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 67-72.

Kixmüller D, Junker R: Analytik korpuskulärer Blutbestandteile. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 61-65.

Junker R, Petersmann A, Luppa P: Relevanz von POCT im Gesundheitswesen. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 9-17.

Luppa P, Junker R, Langer C: Definitionen und Anwendungsgebiete. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 3-8.

Leypoldt F, Magnus, T, Voltz R: Paraneoplastische neurologische Syndrome In: Diener, Gerloff, Dieterich: Therapie und Verlauf neurologischer Erkrankungen. Stuttgart: Kohlhammer 2017; 979-989.

Bernard TJ, Poisson S, Branchford BR,  Nowak-Göttl U: Coagulation Disorders and Cerebrovascular Disease in Children. In: Swaiman KF, Ashwal S, Ferriero DM, Schor NF, Finkel RS,  Gropman AL,  Pearl  PL , Shevell M: Swaiman's Pediatric Neurology. New York City: Elsiver 2017; 2007-2017.


Kreuz W., Escuriola Ettingshausen C., Vdovin V., Zozulya N., Plyushch O., Svirin .P, Andreeva T., Bubanská E., Campos M., Benedik-Dolničar M., Jiménez-Yuste V., Kitanovski L., Klukowska A., Momot A., Osmulskaya N., Prieto M., Šalek S.Z., Velasco F., Pavlova A.,Oldenburg J., Knaub S., Jansen M., Belyanskaya L., Walter O.; ObsITI study group.; ObsITI committee. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study. Haemophilia. 2016 Jan;22(1):87-95. doi: 10.1111/hae.12774. PubMed PMID: 26202305.

Feldkamp T., Weiler N., Marx M., Luppa P.B., Junker R. Critical deviations of ionized calcium measurements when using blood gas analyzers to monitor citrate dialysis. Clin Lab 2016;62:2025-2031, Impact-Faktor 0.936 (IF von 2015)

Arning A., Jeibmann A., Köhnemann S., Brokinkel B., Ewelt C., Berger K., Wellmann J., Nowak-Göttl U., Stummer W., Stoll M., Holling M. ADAMTS genes and the risk of cerebral aneurysm. J Neurosurg. 2016 Aug;125(2):269-74. doi: 10.3171/2015.7.JNS154.

Gersing A.S., Faymonville A.M,. Schwaiger B.J., Leypoldt F., Siemonsen S., Zimmer C., Magnus T., Fiehler J. Quantitative T2* mapping reveals early temporo-spatial dynamics in an ischemic stroke model. J. Neurosci. Methods. 2016 Feb 1;259:83-9. doi: 10.1016/j.jneumeth.2015.11.018. Epub 2015 Nov 29.

Graus F., Titulaer M.J., Balu R., Benseler S., Bien C.G., Cellucci T., Cortese I., Dale R.C., Gelfand J.M., Geschwind M., Glaser C.A., Honnorat J., Höftberger R., Iizuka T., Irani S.R., Lancaster E., Leypoldt F., Prüss H., Rae-Grant A., Reindl M., Rosenfeld M.R., Rostásy K., Saiz A., Venkatesan A., Vincent A., Wandinger K.P., Waters P., Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9

Gövert F., Witt K., Erro R., Hellriegel H., Paschen S., Martinez-Hernandez E., Wandinger K.P., Deuschl G., Dalmau J., Leypoldt F. Orthostatic myoclonus associated with Caspr2 antibodies. Neurology. 2016 Apr 5;86(14):1353-5. doi: 10.1212/WNL.0000000000002547

Werwitzke S., Geisen U., Nowak-Göttl U., Eichler H., Stephan B., Scholz U., Holstein K., Klamroth R., Knöbl P., Huth-Kühne A., Bomke B., Tiede A. Diagnostic and Prognostic Value of Factor VIII Binding Antibodies in Acquired Hemophilia A: Data from the GTH-AH 01/2010 Study. J. Thromb. Haemost. 2016 May;14(5):940-7. doi: 10.1111/jth.13304. Epub 2016 Apr 22.

Brüggemann N., Wandinger K.P., Gaig C., Sprenger A., Junghanns K., Helmchen C., Münchau A. Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies. Mov Disord. 2016 May;31(5):762-4. doi: 10.1002/mds.26608.

Erdur H., Scholz V., Streitz M., Hammer M., Meisel C., Schönemann C., Wandinger K.P., Rosche B. EBNA1 antigen-specific CD8+ Tcells in cerebrospinal fluid of patients with multiple sclerosis. J. Neuroimmunol. 2016 May 15;294:14-7. doi: 10.1016/j.jneuroim.2016.03.010. Epub 2016 Mar 19.

Brüggemann N., Wandinger K.P., Gaig C., Sprenger A., Junghanns K., Helmchen C., Münchau A. Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies. Mov. Disord. 2016 May;31(5):762-4. doi: 10.1002/mds.26608. Epub 2016 Mar 31. No abstract available.

Kuhle J., Hardmeier M., Disanto G., Gugleta K., Ecsedi M., Lienert C., Amato M.P., Baum K., Buttmann M., Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M., D'Hooghe M., Hutchinson M., De Keyser J., Kieseier B.C., Kümpfel T., Rio J., Polman C., Roullet E., Stolz C., Vass K., Wandinger K.P., Kappos L;. A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.European Long-term Follow-up Study Group in Interferon β-1b in Secondary-progressive Multiple Sclerosis.. Mult Scler. 2016 Apr;22(4):533-43. doi: 10.1177/1352458515594440.

Strauss T., Elisha N., Ravid B., Rosenberg N., Lubetsky A., Levy-Mendelovich S., Morag I., Nowak Göttl U., Kenet G. Activity of Von Willebrand factor and levels of  VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Blood Cells Mol Dis. 2016 Dec 29. pii: S1079-9796(16)30161-9. doi: 10.1016/j.bcmd.2016.12.013. [Epub ahead of print] PubMed PMID: 28087247.

Neuner B, von Mackensen S, Holzhauer S, Funk S, Klamroth R, Kurnik K, Krümpel A, Halimeh S, Reinke S, Frühwald M, Nowak-Göttl U. Health-Related Quality of Life in Children and Adolescents with Hereditary Bleeding Disorders and in Children and Adolescents with Stroke: Cross-Sectional Comparison to Siblings and Peers. Biomed. Res. Int. 2016;2016:1579428. doi: 10.1155/2016/1579428. Epub 2016 May 15.

Limperger V., Kenet G., Goldenberg N.A., Heller C., Holzhauer S., Junker R., Klostermeier U.C., Knoefler R., Kurnik K., Krümpel A., Mesters R., Stach M., Young G., Nowak-Göttl U. Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study.  Br J Haematol. 2016 Oct;175(1):133-40. doi: 10.1111/bjh.14192

van Sonderen A., Ariño H., Petit-Pedrol M., Leypoldt F., Körtvélyessy P., Wandinger K.P., Lancaster E., Wirtz P.W., Schreurs M.W., Sillevis Smitt P.A., Graus F., Dalmau J., Titulaer M.J. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016 Aug 2;87(5):521-8. doi: 10.1212/WNL.0000000000002917.

Stoll M., Rühle F., Witten A., Barysenka A., Arning A., Strauss C., Nowak-Göttl U. Rare Variants in the ADAMTS13 VWF Binding Domain Contribute to Pediatric Stroke. Circ Cardiovasc Genet. 2016 Aug;9(4):357-67. doi: 10.1161/CIRCGENETICS.115.001184.

Lechner C., Baumann M., Hennes E.M., Schanda K., Marquard K., Karenfort M., Leiz S., Pohl D., Venkateswaran S., Pritsch M., Koch J., Schimmel M., Häusler M., Klein A., Blaschek A., Thiels C., Lücke T., Gruber-Sedlmayr U., Kornek B., Hahn A., Leypoldt F., Sandrieser T., Gallwitz H., Stoffels J., Korenke C., Reindl M., Rostásy K. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J. Neurol. Neurosurg. Psychiatry. 2016 Aug;87(8):897-905. doi: 10.1136/jnnp-2015-311743. Epub 2015 Dec 8.

van Gerpen J.A., Ahlskog J.E., Chen R., Fung V.S., Hallett M., Gövert F., Deuschl G., Leypoldt F. Orthostatic myoclonus associated with Caspr2 antibodies. Neurology. 2016 Sep 13;87(11):1187-8. doi: 10.1212/WNL.0000000000003140.

Nowak-Göttl U., Kehrel B.E. Haemostasis - an indispensable, cross.sectional medical discipline. Thromb Haemost. 2016 Sep 27;116(4):595-6. doi: 10.1160/TH16-08-0648.

Hartmann S., Biliouris K., Lesko L..J, Nowak-Göttl U., Trame M.N. Quantitative Systems Pharmacology Model to Predict the Effect of Commonly Used Anticoagulants on the Human Coagulation Network. CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):554-564. doi: 10.1002/psp4.12111.

Jarius S., Ringelstein M., Haas J., Serysheva I.I., Komorowski L., Fechner K., Wandinger K.P., Albrecht P., Hefter H., Moser A., Neuen-Jacob E., Hartung H.P., Wildemann B., Aktas O. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy. J Neuroinflammation. 2016 Oct 24;13(1):278.

Brüwer G., Limperger V., Kenet G., Klostermeier U.C., Shneyder M., Degenhardt F., Finckh U., Heller C., Holzhauer S., Trappe R., Kentouche K., Knoefler R., Kurnik K., Krümpel A., Lauten M., Manner D., Mesters R., Junker R., Nowak-Göttl U. Impact of high rist thrombophilia status of recurrence among children and adults with VTE: An observational multicenter cohort study. Blood Cells Mol Dis. 2016 Nov;62:24-31. doi: 10.1016/j.bcmd.2016.10.024.

Lewerenz J., Jarius S., Wildemann B., Wandinger K.P., Leypoldt F. [Autoantibody-associated autoimmune encephalitis and cerebellitis : Clinical presentation, diagnostic work-up and treatment]. Nervenarzt. 2016 Dec;87(12):1293-1299.

Finke C., Prüss H., Heine J., Reuter S., Kopp U.A., Wegner F., Then Bergh F., Koch S., Jansen O., Münte T., Deuschl G., Ruprecht K., Stöcker W., Wandinger K.P., Paul .F, Bartsch T. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis with Leicine.Rich, Glioma-Inactivated 1 Antibodies. JAMA Neurol. 2016 Nov 21. doi: 10.1001/jamaneurol.2016.4226. [Epub ahead of print]

Nowak-Göttl U., Clausnizer H., Kowalski D., Limperger V., Krümpel A,. Shneyder M., Reinke S., Rocke A., Juhl D., Steppat D., Krause M. Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disorders.Blood Cells Mol Dis. 2016 Nov 12. pii: S1079-9796(16)30165-6. doi: 10.1016/j.bcmd.2016.11.010. [Epub ahead of print]

Krause M., Henningsen A., Torge A., Juhl D., Junker R., Kenet G., Kowalski D., Limperger V., Mesters R., Anonymous, Rocke A., Shneyder M., Clausnizer H., Schiesewitz H., Nowak-Göttl U. Impact of gender on safty and efficacy of Rivaroxaban in adolescents & young adults with venous tromboembolism. Thromb Res. 2016 Dec;148:145-151. doi: 10.1016/j.thromres.2016.09.007.

Miske R., Gross C.C., Scharf M., Golombeck K.S., Hartwig M., Bhatia U., Schulte-Mecklenbeck A., Bönte K., Strippel C., Schöls L., Synofzik M., Lohmann H., Dettmann I.M., Deppe M., Mindorf S., Warnecke T., Denno Y., Teegen B., Probst C., Brakopp S., Wandinger K..P, Wiendl H., Stöcker W., Meuth S.G., Komorowski L., Melzer N. Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm. 2016 Dec 5;4(1):e307.

Nowak-Göttl U., Limperger V., Kenet G., Degenhardt .F, Arlt R., Domschikowski J.,Clausnizer H., Liebsch J., Junker R., Steppat D. Developmental hemostasis: Alifespan from neonates and pregnancy to the young and elderly adult in a Europeanwhite population. Blood Cells Mol Dis. 2016 Dec 5. pii: S1079-9796(16)30268-6.doi: 10.1016/j.bcmd.2016.11.012. [Epub ahead of print] PubMed PMID: 28017497.

Kenet G., Limperger V., Shneyder M., Nowak-Göttl U.. Risk factors for symptomaticvenous and arterial thromboembolism in newborns, children and adolescents - Whatdid we learn within the last 20years? Blood Cells Mol Dis. 2016 Dec 14. pii:S1079-9796(16)30274-1. doi: 10.1016/j.bcmd.2016.12.003. [Epub ahead of print]PubMed PMID: 28010922.
Rühle F., Witten A., Barysenka A., Huge A., Arning A., Heller C., Krümpel A.,Mesters R., Franke A., Lieb W., Riemenschneider M., Hiersche M., Limperger V., Nowak-Göttl U., Stoll M. Rare genetic variants in SMAP1, B3GAT2 and RIMS1contribute to pediatric venous thromboembolism. Blood. 2016 Dec 23. pii:blood-2016-07-728840. doi: 10.1182/blood-2016-07-728840. [Epub ahead of print]PubMed PMID: 28011674.

Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, Apostolou P,

Arnold N, Arun BK, Barrowdale D, Benitez J, Berger R, Berthet P, Borg A, Buys SS, Caldes T, Carter J, Chiquette J, Claes KB, Couch FJ, Cybulski C, Daly MB, de la Hoya M, Diez O, Domchek SM, Nathanson KL, Durda K, Ellis S; EMBRACE, Evans DG, Foretova L, Friedman E, Frost D, Ganz PA, Garber J, Glendon G, Godwin AK, Greene MH, Gronwald J, Hahnen E, Hallberg E, Hamann U, Hansen TV; HEBON, Imyanitov EN,Isaacs C, Jakubowska A, Janavicius R, Jaworska-Bieniek K, John EM, Karlan BY, Kaufman B, Investigators K, Kwong A, Laitman Y, Lasset C, Lazaro C, Lester J, Loman N, Lubinski J, Manoukian S, Mitchell G, Montagna M, Neuhausen SL, Nevanlinna H, Niederacher D, Nussbaum RL, Offit K, Olah E, Olopade OI, Park SK, Piedmonte M, Radice P, Rappaport-Fuerhauser C, Rookus MA, Seynaeve C, Simard J, Singer CF, Soucy P, Southey M, Stoppa-Lyonnet D, Sukiennicki G, Szabo CI, Tancredi M, Teixeira MR, Teo SH, Terry MB, Thomassen M, Tihomirova L, Tischkowitz M, Toland AE, Toloczko-Grabarek A, Tung N, van Rensburg EJ, Villano D, Wang-Gohrke S, Wappenschmidt B, Weitzel JN, Zidan J, Zorn KK, McGuffog L, Easton D, Chenevix-Trench G, Antoniou AC, Ramus SJ.Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res. 2016 Nov 11;18(1):112. PubMed PMID: 27836010; PubMed Central PMCID:PMC5106833.

 Hamdi Y, Soucy P, Kuchenbaeker KB, Pastinen T, Droit A, Lemaçon A, Adlard J, Aittomäki K, Andrulis IL, Arason A, Arnold N, Arun BK, Azzollini J, Bane A, Barjhoux L, Barrowdale D, Benitez J, Berthet P, Blok MJ, Bobolis K, Bonadona V, Bonanni B, Bradbury AR, Brewer C, Buecher B, Buys SS, Caligo MA, Chiquette J, Chung WK, Claes KB, Daly MB, Damiola F, Davidson R, De la Hoya M, De Leeneer K, Diez O, Ding YC, Dolcetti R, Domchek SM, Dorfling CM, Eccles D, Eeles R, Einbeigi Z, Ejlertsen B; EMBRACE, Engel C, Gareth Evans D, Feliubadalo L, Foretova L, Fostira F, Foulkes WD, Fountzilas G, Friedman E, Frost D, Ganschow P, Ganz PA, Garber J, Gayther SA; GEMO Study Collaborators, Gerdes AM, Glendon G, Godwin AK, Goldgar DE, Greene MH, Gronwald J, Hahnen E, Hamann U, Hansen TV, Hart S, Hays JL; HEBON, Hogervorst FB, Hulick PJ, Imyanitov EN, Isaacs C, Izatt L, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, Joseph V, Just W, Kaczmarek K, Karlan BY; KConFab Investigators, Kets CM, Kirk J, Kriege M, Laitman Y, Laurent M, Lazaro C, Leslie G, Lester J, Lesueur F, Liljegren A, Loman N, Loud JT, Manoukian S, Mariani M, Mazoyer S, McGuffog L, Meijers-Heijboer HE, Meindl A, Miller A, Montagna M, Mulligan AM, Nathanson KL, Neuhausen SL, Nevanlinna H, Nussbaum RL, Olah E, Olopade OI, Ong KR, Oosterwijk JC, Osorio A, Papi L, Park SK, Pedersen IS, Peissel B, Segura PP, Peterlongo P, Phelan CM, Radice P, Rantala J, Rappaport-Fuerhauser C, Rennert G, Richardson A, Robson M, Rodriguez GC, Rookus MA, Schmutzler RK, Sevenet N, Shah PD, Singer CF, Slavin TP, Snape K, Sokolowska J, Sønderstrup IM, Southey M, Spurdle AB, Stadler Z, Stoppa-Lyonnet D, Sukiennicki G, Sutter C, Tan Y, Tea MK, Teixeira MR, Teulé A, Teo SH, Terry MB, Thomassen M, Tihomirova L, Tischkowitz M, Tognazzo S, Toland AE, Tung N, van den Ouweland AM, van der Luijt RB, van Engelen K, van Rensburg EJ, Varon-Mateeva R, Wappenschmidt B, Wijnen JT, Rebbeck T, Chenevix-Trench G, Offit K, Couch FJ, Nord S, Easton DF, Antoniou AC, Simard J. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Res Treat. 2017 Jan;161(1):117-134. doi: 10.1007/s10549-016-4018-2. Epub 2016 Oct 28. PubMed PMID: 27796716; PubMed Central PMCID: PMC5222911.

de la Hoya M, Soukarieh O, López-Perolio I, Vega A, Walker LC, van Ierland Y, Baralle D, Santamariña M, Lattimore V, Wijnen J, Whiley P, Blanco A, Raponi M, Hauke J, Wappenschmidt B, Becker A, Hansen TV, Behar R, Investigators K, Niederacher D, Arnold N, Dworniczak B, Steinemann D, Faust U, Rubinstein W, Hulick PJ, Houdayer C, Caputo SM, Castera L, Pesaran T, Chao E, Brewer C, Southey MC, van Asperen CJ, Singer CF, Sullivan J, Poplawski N, Mai P, Peto J, Johnson N, Burwinkel B, Surowy H, Bojesen SE, Flyger H, Lindblom A, Margolin S, Chang-Claude J, Rudolph A, Radice P, Galastri L, Olson JE, Hallberg E, Giles GG, Milne RL, Andrulis IL, Glendon G, Hall P, Czene K, Blows F, Shah M, Wang Q, Dennis J, Michailidou K, McGuffog L, Bolla MK, Antoniou AC, Easton DF, Couch FJ, Tavtigian S, Vreeswijk MP, Parsons M, Meeks HD, Martins A, Goldgar DE, Spurdle AB. Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Hum Mol Genet. 2016 Jun 1;25(11):2256-2268. Epub 2016 Mar 23. PubMed PMID: 27008870; PubMed Central PMCID: PMC5081057.

Andradas C, Blasco-Benito S, Castillo-Lluva S, Dillenburg-Pilla P, Diez-Alarcia R, Juanes-García A, García-Taboada E, Hernando-Llorente R, Soriano J, Hamann S, Wenners A, Alkatout I, Klapper W, Rocken C, Bauer M, Arnold N, Quintanilla M, Megías D, Vicente-Manzanares M, Urigüen L, Gutkind JS, Guzmán M, Pérez-Gómez E, Sánchez C Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer. Oncotarget. 2016 Jul 26;7(30):47565-47575. doi: 10.18632/oncotarget.10206. PubMed PMID: 27340777; PubMed Central PMCID: PMC5216961.

Heilmann T, Dittmann L, van Mackelenbergh M, Mundhenke C, Weimer J, Arnold N, Maass N, Schem C. Head-to-head comparison of the impact of Aurora A, Aurora B, Repp86, CDK1, CDK2 and Ki67 expression in two of the most relevant gynaecologica tumor entities. Arch Gynecol Obstet. 2016 Oct;294(4):813-23. doi: 10.1007/s00404-016-4104-z. Epub 2016 Apr 21. PubMed PMID: 27101368.

Kast K, Rhiem K, Wappenschmidt B, Hahnen E, Hauke J, Bluemcke B, Zarghooni V, Herold N, Ditsch N, Kiechle M, Braun M, Fischer C, Dikow N, Schott S, Rahner N, Niederacher D, Fehm T, Gehrig A, Mueller-Reible C, Arnold N, Maass N, Borck G, de Gregorio N, Scholz C, Auber B, Varon-Manteeva R, Speiser D, Horvath J, Lichey N, Wimberger P, Stark S, Faust U, Weber BH, Emons G, Zachariae S, Meindl A, Schmutzler RK, Engel C; German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC). Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet. 2016 Jul;53(7):465-71. doi: 10.1136/jmedgenet-2015-103672. Epub 2016 Feb 29. PubMed PMID: 26928436.

Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, Beesley J, Healey CS, Kar S, Pooley KA, Lopez-Knowles E, Dicks E, Barrowdale D, Sinnott-Armstrong NA, Sallari RC, Hillman KM, Kaufmann S, Sivakumaran H, Moradi Marjaneh M, Lee JS, Hills M, Jarosz M, Drury S, Canisius S, Bolla MK, Dennis J, Wang Q, Hopper JL, Southey MC, Broeks A, Schmidt MK, Lophatananon A, Muir K, Beckmann MW, Fasching PA, Dos-Santos-Silva I, Peto J, Sawyer EJ, Tomlinson I, Burwinkel B, Marme F, Guénel P, Truong T, Bojesen SE, Flyger H, González-Neira A, Perez JI, Anton-Culver H, Eunjung L, Arndt V, Brenner H, Meindl A, Schmutzler RK, Brauch H, Hamann U, Aittomäki K, Blomqvist C, Ito H, Matsuo K, Bogdanova N, Dörk T, Lindblom A, Margolin S, Kosma VM, Mannermaa A, Tseng CC, Wu AH, Lambrechts D, Wildiers H, Chang-Claude J, Rudolph A, Peterlongo P, Radice P, Olson JE, Giles GG, Milne RL, Haiman CA, Henderson BE, Goldberg MS, Teo SH, Yip CH, Nord S, Borresen-Dale AL, Kristensen V, Long J, Zheng W, Pylkäs K, Winqvist R, Andrulis IL, Knight JA, Devilee P, Seynaeve C, Figueroa J, Sherman ME, Czene K, Darabi H, Hollestelle A, van den Ouweland AM, Humphreys K, Gao YT, Shu XO, Cox A, Cross SS, Blot W, Cai Q, Ghoussaini M, Perkins BJ, Shah M, Choi JY, Kang D, Lee SC, Hartman M, Kabisch M, Torres D, Jakubowska A, Lubinski J, Brennan P, Sangrajrang S, Ambrosone CB, Toland AE, Shen CY, Wu PE, Orr N, Swerdlow A, McGuffog L, Healey S, Lee A, Kapuscinski M, John EM, Terry MB, Daly MB, Goldgar DE, Buys SS, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Neuhausen SL, Ejlertsen B, Hansen TV, Osorio A, Benitez J, Rando R, Weitzel JN, Bonanni B, Peissel B, Manoukian S, Papi L, Ottini L, Konstantopoulou I, Apostolou P, Garber J, Rashid MU, Frost D; EMBRACE, Izatt L, Ellis S, Godwin AK, Arnold N, Niederacher D, Rhiem K, Bogdanova-Markov N, Sagne C, Stoppa-Lyonnet D, Damiola F; GEMO Study Collaborators, Sinilnikova OM, Mazoyer S, Isaacs C, Claes KB, De Leeneer K, de la Hoya M, Caldes T, Nevanlinna H, Khan S, Mensenkamp AR; HEBON, Hooning MJ, Rookus MA, Kwong A, Olah E, Diez O, Brunet J, Pujana MA, Gronwald J, Huzarski T, Barkardottir RB, Laframboise R, Soucy P, Montagna M, Agata S, Teixeira MR; kConFab Investigators, Park SK, Lindor N, Couch FJ, Tischkowitz M, Foretova L, Vijai J, Offit K, Singer CF, Rappaport C, Phelan CM, Greene MH, Mai PL, Rennert G, Imyanitov EN, Hulick PJ, Phillips KA, Piedmonte M, Mulligan AM, Glendon G, Bojesen A, Thomassen M, Caligo MA, Yoon SY, Friedman E, Laitman Y, Borg A, von Wachenfeldt A, Ehrencrona H, Rantala J, Olopade OI, Ganz PA, Nussbaum RL, Gayther SA, Nathanson KL, Domchek SM, Arun BK, Mitchell G, Karlan BY, Lester J, Maskarinec G, Woolcott C, Scott C, Stone J, Apicella C, Tamimi R, Luben R, Khaw KT, Helland Å, Haakensen V, Dowsett M, Pharoah PD, Simard J, Hall P, García-Closas M, Vachon C, Chenevix-Trench G, Antoniou AC, Easton DF, Edwards SL. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat Genet. 2016 Apr;48(4):374-86. doi: 10.1038/ng.3521. Epub 2016 Feb 29. PubMed PMID: 26928228; PubMed Central PMCID: PMC4938803.

Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, Nussbaum RL, Olopade OI, Rantala J, Yoon SY, Caligo MA, Spugnesi L, Bojesen A, Pedersen IS, Thomassen M, Jensen UB, Toland AE, Senter L, Andrulis IL, Glendon G, Hulick PJ, Imyanitov EN, Greene MH, Mai PL, Singer CF, Rappaport-Fuerhauser C, Kramer G, Vijai J, Offit K, Robson M, Lincoln A, Jacobs L, Machackova E, Foretova L, Navratilova M, Vasickova P, Couch FJ, Hallberg E, Ruddy KJ, Sharma P, Kim SW; kConFab Investigators, Teixeira MR, Pinto P, Montagna M, Matricardi L, Arason A, Johannsson OT, Barkardottir RB, Jakubowska A, Lubinski J, Izquierdo A, Pujana MA, Balmaña J, Diez O, Ivady G, Papp J, Olah E, Kwong A; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Nevanlinna H, Aittomäki K, Perez Segura P, Caldes T, Van Maerken T, Poppe B, Claes KB, Isaacs C, Elan C, Lasset C, Stoppa-Lyonnet D, Barjhoux L, Belotti M, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Hahnen E, Kast K, Arnold N, Varon-Mateeva R, Wand D, Godwin AK, Evans DG, Frost D, Perkins J, Adlard J, Izatt L, Platte R, Eeles R, Ellis S; EMBRACE, Hamann U, Garber J, Fostira F, Fountzilas G, Pasini B, Giannini G, Rizzolo P, Russo A, Cortesi L, Papi L, Varesco L, Palli D, Zanna I, Savarese A, Radice P, Manoukian S, Peissel B, Barile M, Bonanni B, Viel A, Pensotti V, Tommasi S, Peterlongo P, Weitzel JN, Osorio A, Benitez J, McGuffog L, Healey S, Gerdes AM, Ejlertsen B, Hansen TV, Steele L, Ding YC, Tung N, Janavicius R, Goldgar DE, Buys SS, Daly MB, Bane A, Terry MB, John EM, Southey M, Easton DF, Chenevix-Trench G, Antoniou AC, Ottini L. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 2016 Feb 9;18(1):15. doi: 10.1186/s13058-016-0671-y. PubMed PMID: 26857456; PubMed Central PMCID: PMC4746828.

 Huang X, Weimer J, von Wurmb-Schwark N, Fredrik R, Arnold N, Schem C. Alteration of STR profiles in ovarian carcinoma cells during primary culture. Arch Gynecol Obstet. 2016 Aug;294(2):369-76. doi: 10.1007/s00404-016-4018-9. Epub 2016 Jan 29. PubMed PMID: 26825732.